nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—FGFR3—Endochondral Ossification—SOX9—degenerative disc disease	0.0393	0.0393	CbGpPWpGaD
Ponatinib—KIT—Differentiation Pathway—GDF5—degenerative disc disease	0.035	0.035	CbGpPWpGaD
Ponatinib—FGFR3—Endochondral Ossification—ADAMTS5—degenerative disc disease	0.0329	0.0329	CbGpPWpGaD
Ponatinib—FGFR3—Endochondral Ossification—ADAMTS4—degenerative disc disease	0.028	0.028	CbGpPWpGaD
Ponatinib—KDR—Integrin cell surface interactions—COL9A3—degenerative disc disease	0.028	0.028	CbGpPWpGaD
Ponatinib—FGFR3—Neural Crest Differentiation—SOX9—degenerative disc disease	0.0273	0.0273	CbGpPWpGaD
Ponatinib—FGFR1—Endochondral Ossification—SOX9—degenerative disc disease	0.0252	0.0252	CbGpPWpGaD
Ponatinib—RET—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—degenerative disc disease	0.0243	0.0243	CbGpPWpGaD
Ponatinib—KDR—Integrin cell surface interactions—COL9A2—degenerative disc disease	0.0218	0.0218	CbGpPWpGaD
Ponatinib—FGFR1—Endochondral Ossification—ADAMTS5—degenerative disc disease	0.0211	0.0211	CbGpPWpGaD
Ponatinib—FGFR1—NCAM signaling for neurite out-growth—COL9A3—degenerative disc disease	0.0201	0.0201	CbGpPWpGaD
Ponatinib—LYN—Alpha-synuclein signaling—PARK2—degenerative disc disease	0.0201	0.0201	CbGpPWpGaD
Ponatinib—FGFR4—Signaling by PDGF—COL9A3—degenerative disc disease	0.0193	0.0193	CbGpPWpGaD
Ponatinib—FGFR2—Neural Crest Differentiation—SOX9—degenerative disc disease	0.0187	0.0187	CbGpPWpGaD
Ponatinib—FGFR1—Endochondral Ossification—ADAMTS4—degenerative disc disease	0.0179	0.0179	CbGpPWpGaD
Ponatinib—FGFR3—Endochondral Ossification—MMP13—degenerative disc disease	0.0177	0.0177	CbGpPWpGaD
Ponatinib—FGFR1—Neural Crest Differentiation—SOX9—degenerative disc disease	0.0175	0.0175	CbGpPWpGaD
Ponatinib—LCK—Alpha-synuclein signaling—PARK2—degenerative disc disease	0.0165	0.0165	CbGpPWpGaD
Ponatinib—FGFR1—NCAM signaling for neurite out-growth—COL9A2—degenerative disc disease	0.0157	0.0157	CbGpPWpGaD
Ponatinib—FGFR4—Signaling by PDGF—COL9A2—degenerative disc disease	0.015	0.015	CbGpPWpGaD
Ponatinib—SRC—Alpha-synuclein signaling—PARK2—degenerative disc disease	0.0146	0.0146	CbGpPWpGaD
Ponatinib—FGFR3—Signaling by PDGF—COL9A3—degenerative disc disease	0.0143	0.0143	CbGpPWpGaD
Ponatinib—SRC—NCAM signaling for neurite out-growth—COL9A3—degenerative disc disease	0.0128	0.0128	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—GDF5—degenerative disc disease	0.0115	0.0115	CbGpPWpGaD
Ponatinib—FGFR1—Endochondral Ossification—MMP13—degenerative disc disease	0.0113	0.0113	CbGpPWpGaD
Ponatinib—FGFR3—Signaling by PDGF—COL9A2—degenerative disc disease	0.0111	0.0111	CbGpPWpGaD
Ponatinib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP13—degenerative disc disease	0.0101	0.0101	CbGpPWpGaD
Ponatinib—SRC—NCAM signaling for neurite out-growth—COL9A2—degenerative disc disease	0.01	0.01	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by PDGF—COL9A3—degenerative disc disease	0.00981	0.00981	CbGpPWpGaD
Ponatinib—KIT—Signaling by PDGF—COL9A3—degenerative disc disease	0.00963	0.00963	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—ADAMTS5—degenerative disc disease	0.00922	0.00922	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—ADAMTS3—degenerative disc disease	0.00922	0.00922	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—COL9A3—degenerative disc disease	0.00922	0.00922	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by PDGF—COL9A3—degenerative disc disease	0.00914	0.00914	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by PDGF—COL9A3—degenerative disc disease	0.00912	0.00912	CbGpPWpGaD
Ponatinib—ABL1—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—degenerative disc disease	0.00837	0.00837	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—ADAMTS4—degenerative disc disease	0.00784	0.00784	CbGpPWpGaD
Ponatinib—KDR—Axon guidance—COL9A3—degenerative disc disease	0.00783	0.00783	CbGpPWpGaD
Ponatinib—BCR—Disease—CHST3—degenerative disc disease	0.00771	0.00771	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by PDGF—COL9A2—degenerative disc disease	0.00765	0.00765	CbGpPWpGaD
Ponatinib—KIT—Signaling by PDGF—COL9A2—degenerative disc disease	0.00752	0.00752	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—COL9A2—degenerative disc disease	0.0072	0.0072	CbGpPWpGaD
Ponatinib—SRC—Oncostatin M Signaling Pathway—MMP13—degenerative disc disease	0.00715	0.00715	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by PDGF—COL9A2—degenerative disc disease	0.00713	0.00713	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by PDGF—COL9A2—degenerative disc disease	0.00712	0.00712	CbGpPWpGaD
Ponatinib—SRC—AGE/RAGE pathway—MMP13—degenerative disc disease	0.00706	0.00706	CbGpPWpGaD
Ponatinib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—degenerative disc disease	0.00679	0.00679	CbGpPWpGaD
Ponatinib—LCK—Signaling by PDGF—COL9A3—degenerative disc disease	0.00659	0.00659	CbGpPWpGaD
Ponatinib—CYP3A5—Metapathway biotransformation—CHST3—degenerative disc disease	0.00623	0.00623	CbGpPWpGaD
Ponatinib—KDR—Axon guidance—COL9A2—degenerative disc disease	0.00611	0.00611	CbGpPWpGaD
Ponatinib—SRC—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—degenerative disc disease	0.0061	0.0061	CbGpPWpGaD
Ponatinib—SRC—Signaling by PDGF—COL9A3—degenerative disc disease	0.00583	0.00583	CbGpPWpGaD
Ponatinib—FGFR1—Axon guidance—COL9A3—degenerative disc disease	0.00576	0.00576	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—COL9A3—degenerative disc disease	0.00559	0.00559	CbGpPWpGaD
Ponatinib—FGFR4—Disease—CHST3—degenerative disc disease	0.00543	0.00543	CbGpPWpGaD
Ponatinib—CYP2C8—Metapathway biotransformation—CHST3—degenerative disc disease	0.00539	0.00539	CbGpPWpGaD
Ponatinib—LCK—Signaling by PDGF—COL9A2—degenerative disc disease	0.00515	0.00515	CbGpPWpGaD
Ponatinib—LYN—Axon guidance—COL9A3—degenerative disc disease	0.00507	0.00507	CbGpPWpGaD
Ponatinib—ABL1—Axon guidance—COL9A3—degenerative disc disease	0.00505	0.00505	CbGpPWpGaD
Ponatinib—BCR—Disease—RPL34—degenerative disc disease	0.00497	0.00497	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—MMP13—degenerative disc disease	0.00496	0.00496	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—BMP2—degenerative disc disease	0.00479	0.00479	CbGpPWpGaD
Ponatinib—SRC—Oncostatin M Signaling Pathway—MMP3—degenerative disc disease	0.00479	0.00479	CbGpPWpGaD
Ponatinib—SRC—Senescence and Autophagy in Cancer—BMP2—degenerative disc disease	0.00471	0.00471	CbGpPWpGaD
Ponatinib—SRC—Signaling by PDGF—COL9A2—degenerative disc disease	0.00455	0.00455	CbGpPWpGaD
Ponatinib—FGFR1—Axon guidance—COL9A2—degenerative disc disease	0.0045	0.0045	CbGpPWpGaD
Ponatinib—FGFR4—Adaptive Immune System—PARK2—degenerative disc disease	0.00446	0.00446	CbGpPWpGaD
Ponatinib—CYP2D6—Metapathway biotransformation—CHST3—degenerative disc disease	0.00443	0.00443	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—COL9A2—degenerative disc disease	0.00436	0.00436	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—COL9A3—degenerative disc disease	0.00411	0.00411	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—COL9A3—degenerative disc disease	0.00409	0.00409	CbGpPWpGaD
Ponatinib—FGFR3—Disease—CHST3—degenerative disc disease	0.00402	0.00402	CbGpPWpGaD
Ponatinib—LYN—Axon guidance—COL9A2—degenerative disc disease	0.00396	0.00396	CbGpPWpGaD
Ponatinib—ABL1—Axon guidance—COL9A2—degenerative disc disease	0.00394	0.00394	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—COL9A3—degenerative disc disease	0.00368	0.00368	CbGpPWpGaD
Ponatinib—SRC—BDNF signaling pathway—BMP2—degenerative disc disease	0.00366	0.00366	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—COL9A3—degenerative disc disease	0.00362	0.00362	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—COL9A3—degenerative disc disease	0.0036	0.0036	CbGpPWpGaD
Ponatinib—FGFR4—Disease—RPL34—degenerative disc disease	0.0035	0.0035	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—MMP3—degenerative disc disease	0.00332	0.00332	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—PARK2—degenerative disc disease	0.0033	0.0033	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—COL9A2—degenerative disc disease	0.00321	0.00321	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—COL9A2—degenerative disc disease	0.0032	0.0032	CbGpPWpGaD
Ponatinib—CYP3A4—Metapathway biotransformation—CHST3—degenerative disc disease	0.0029	0.0029	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—COL9A3—degenerative disc disease	0.00288	0.00288	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—COL9A2—degenerative disc disease	0.00287	0.00287	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—COL9A2—degenerative disc disease	0.00282	0.00282	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—COL9A2—degenerative disc disease	0.00281	0.00281	CbGpPWpGaD
Ponatinib—FGFR2—Disease—CHST3—degenerative disc disease	0.00276	0.00276	CbGpPWpGaD
Ponatinib—KIT—Disease—CHST3—degenerative disc disease	0.00271	0.00271	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—PARK2—degenerative disc disease	0.0027	0.0027	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—COL9A3—degenerative disc disease	0.00262	0.00262	CbGpPWpGaD
Ponatinib—FGFR3—Disease—RPL34—degenerative disc disease	0.00259	0.00259	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CHST3—degenerative disc disease	0.00258	0.00258	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CHST3—degenerative disc disease	0.00257	0.00257	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—CHST3—degenerative disc disease	0.00228	0.00228	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—PARK2—degenerative disc disease	0.00227	0.00227	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—COL9A2—degenerative disc disease	0.00225	0.00225	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—PARK2—degenerative disc disease	0.00223	0.00223	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—COL9A3—degenerative disc disease	0.00213	0.00213	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—BMP2—degenerative disc disease	0.00213	0.00213	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—PARK2—degenerative disc disease	0.00211	0.00211	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—PARK2—degenerative disc disease	0.00211	0.00211	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—COL9A2—degenerative disc disease	0.00205	0.00205	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—PARK2—degenerative disc disease	0.002	0.002	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—PARK2—degenerative disc disease	0.00186	0.00186	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—COL9A3—degenerative disc disease	0.00186	0.00186	CbGpPWpGaD
Ponatinib—LCK—Disease—CHST3—degenerative disc disease	0.00186	0.00186	CbGpPWpGaD
Ponatinib—FGFR2—Disease—RPL34—degenerative disc disease	0.00178	0.00178	CbGpPWpGaD
Ponatinib—KIT—Disease—RPL34—degenerative disc disease	0.00175	0.00175	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—COL9A2—degenerative disc disease	0.00167	0.00167	CbGpPWpGaD
Ponatinib—FGFR1—Disease—RPL34—degenerative disc disease	0.00166	0.00166	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—RPL34—degenerative disc disease	0.00166	0.00166	CbGpPWpGaD
Ponatinib—SRC—Disease—CHST3—degenerative disc disease	0.00164	0.00164	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—PARK2—degenerative disc disease	0.00152	0.00152	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—CHST3—degenerative disc disease	0.00151	0.00151	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—BMP2—degenerative disc disease	0.0015	0.0015	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—MMP3—degenerative disc disease	0.00147	0.00147	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—COL9A3—degenerative disc disease	0.00147	0.00147	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—COL9A2—degenerative disc disease	0.00145	0.00145	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—COL9A3—degenerative disc disease	0.00144	0.00144	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—PARK2—degenerative disc disease	0.00137	0.00137	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—COL9A3—degenerative disc disease	0.00137	0.00137	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—COL9A3—degenerative disc disease	0.00136	0.00136	CbGpPWpGaD
Ponatinib—KIT—Immune System—PARK2—degenerative disc disease	0.00135	0.00135	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—PARK2—degenerative disc disease	0.00135	0.00135	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—PARK2—degenerative disc disease	0.00128	0.00128	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—PARK2—degenerative disc disease	0.00128	0.00128	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—COL9A3—degenerative disc disease	0.0012	0.0012	CbGpPWpGaD
Ponatinib—LCK—Disease—RPL34—degenerative disc disease	0.0012	0.0012	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—COL9A2—degenerative disc disease	0.00115	0.00115	CbGpPWpGaD
Ponatinib—LYN—Immune System—PARK2—degenerative disc disease	0.00113	0.00113	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—COL9A2—degenerative disc disease	0.00112	0.00112	CbGpPWpGaD
Ponatinib—ABL1—Immune System—PARK2—degenerative disc disease	0.00112	0.00112	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—BMP2—degenerative disc disease	0.00111	0.00111	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CHST3—degenerative disc disease	0.00108	0.00108	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—COL9A2—degenerative disc disease	0.00107	0.00107	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—COL9A2—degenerative disc disease	0.00106	0.00106	CbGpPWpGaD
Ponatinib—SRC—Disease—RPL34—degenerative disc disease	0.00106	0.00106	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—MMP3—degenerative disc disease	0.00104	0.00104	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—COL9A3—degenerative disc disease	0.000986	0.000986	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—BMP2—degenerative disc disease	0.000965	0.000965	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—COL9A2—degenerative disc disease	0.000939	0.000939	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CHST3—degenerative disc disease	0.000935	0.000935	CbGpPWpGaD
Ponatinib—LCK—Immune System—PARK2—degenerative disc disease	0.000924	0.000924	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—COL9A3—degenerative disc disease	0.000873	0.000873	CbGpPWpGaD
Ponatinib—SRC—Immune System—PARK2—degenerative disc disease	0.000818	0.000818	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CHST3—degenerative disc disease	0.000815	0.000815	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—COL9A2—degenerative disc disease	0.00077	0.00077	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CHST3—degenerative disc disease	0.000768	0.000768	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—MMP3—degenerative disc disease	0.000768	0.000768	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—BMP2—degenerative disc disease	0.000762	0.000762	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—BMP2—degenerative disc disease	0.000748	0.000748	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—BMP2—degenerative disc disease	0.00071	0.00071	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—BMP2—degenerative disc disease	0.000708	0.000708	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—COL9A2—degenerative disc disease	0.000681	0.000681	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—MMP3—degenerative disc disease	0.000669	0.000669	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—BMP2—degenerative disc disease	0.000625	0.000625	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MMP3—degenerative disc disease	0.000528	0.000528	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MMP3—degenerative disc disease	0.000519	0.000519	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—BMP2—degenerative disc disease	0.000512	0.000512	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CHST3—degenerative disc disease	0.000502	0.000502	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MMP3—degenerative disc disease	0.000492	0.000492	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MMP3—degenerative disc disease	0.000491	0.000491	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—BMP2—degenerative disc disease	0.000453	0.000453	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP3—degenerative disc disease	0.000433	0.000433	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP3—degenerative disc disease	0.000355	0.000355	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP3—degenerative disc disease	0.000314	0.000314	CbGpPWpGaD
